Mr. Thomas Scott Duncan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 595 18th St, Astoria, OR 97103 Phone: 503-325-9131 Fax: 503-325-8797 |
Dr. Roy James Little, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2111 Exchange St, Astoria, OR 97103 Phone: 503-325-4321 |
Dr. Angela Stock Nairn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Exchange St, Ste 190, Astoria, OR 97103 Phone: 503-325-5300 Fax: 503-325-5400 |
Patience J. Pine, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2158 Exchange St Ste 304, Astoria, OR 97103 Phone: 503-325-8315 Fax: 503-325-8602 |
Dr. Keith David Klatt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2120 Exchange St, Suite 111, Astoria, OR 97103 Phone: 503-325-0333 Fax: 503-325-6333 |
Alix Cooper, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2158 Exchange St Ste 304, Astoria, OR 97103 Phone: 503-325-8315 Fax: 503-325-8602 |
Dr. Carolyn Iacullo Nygaard, N.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1490 Commercial St Ste 200, Astoria, OR 97103 Phone: 503-741-3636 |
Dr. Kevin J Baxter, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Pier 1 Ste 301, Astoria, OR 97103 Phone: 503-741-3570 Fax: 503-741-3569 |
Scott E Ashley, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2120 Exchange St, Ste 209, Astoria, OR 97103 Phone: 503-338-2993 Fax: 503-338-2996 |
News Archive
Unibased Systems Architecture, Inc. today announced Bay Area Hospital (BAH) in Coos Bay, Oregon successfully implemented the Unibased ForSite2020® periOperative Resource Management System (ORMS). BAH contracted with Unibased for the complete ForSite2020 surgery management system suite in December 2009 with the goal of achieving total perioperative automation and moving forward with their hospital-wide electronic health record (EHR) initiative.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
Fewer people than expected chose to use the COBRA subsidy offered by the federal government, according to an analysis by the Employee Benefit Research Institute, The New York Times Prescriptions blog reports.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012.
› Verified 7 days ago